How many insider trades does FilingIQ track for BIVI?

FilingIQ tracks 78 Form 4 insider transactions for BIVI (BIOVIE INC.), covering filings from Aug 13, 2018 onwards. 4 of those were filed in the last 90 days.

Are BIVI insiders net buyers or net sellers?

Across the full Form 4 history for BIVI, 19 transactions (24%) were open-market purchases and 8 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BIVI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BIVI in?

BIOVIE INC. (BIVI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $10.26M.

BIVI insider trading

NasdaqCM Healthcare

BIOVIE INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

24% / 10%

Market cap

$10.26M

About BIOVIE INC.

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Company website: bioviepharma.com

BIVI insider activity at a glance

FilingIQ has scored 78 insider transactions for BIVI since Aug 13, 2018. The most recent filing in our index is dated Aug 28, 2026.

Across the full history, 19 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BIVI insider trades is 59.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BIVI trades on FilingIQ Raw filings on SEC EDGAR

Latest BIVI Form 4 filings

DO CUONG V President & CEO

P Aug 27, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 805

UNITED THERAPEUTICS Corp

BLLN 188

BillionToOne, Inc.

KYMR 166

Kymera Therapeutics, Inc.

THERMO FISHER SCIENTIFIC INC.

HNGE 122

Hinge Health, Inc.

GH 120

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for BIVI?: FilingIQ tracks 78 Form 4 insider transactions for BIVI (BIOVIE INC.), covering filings from Aug 13, 2018 onwards. 4 of those were filed in the last 90 days.
Are BIVI insiders net buyers or net sellers?: Across the full Form 4 history for BIVI, 19 transactions (24%) were open-market purchases and 8 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BIVI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BIVI in?: BIOVIE INC. (BIVI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $10.26M.

Methodology & sources

Every BIVI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.